Viatris Specialty LLC
Clinical trials sponsored by Viatris Specialty LLC, explained in plain language.
A subsidiary of Viatris, a global pharmaceutical company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New drug aims to ease Post-Surgery pain without opioids
Symptom relief CompletedThis study tested a new drug called MR-107A-02 for treating acute pain after hernia repair surgery. About 579 adults took part, comparing the drug to a placebo and to tramadol, a standard painkiller. The goal was to see if MR-107A-02 reduces pain intensity and the need for extra …
Phase 3 • Sponsor: Viatris Specialty LLC • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New pill could ease Post-Surgery pain without opioids
Symptom relief CompletedThis study tested a new drug called MR-107A-02 for treating acute pain after bunionectomy (foot surgery). 410 adults received either the new drug, a placebo, or tramadol (a standard painkiller). The main goal was to see if MR-107A-02 provides better pain relief than placebo, meas…
Phase 3 • Sponsor: Viatris Specialty LLC • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC